GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » EV-to-EBIT

WIN-Partners Co (TSE:3183) EV-to-EBIT : 6.62 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, WIN-Partners Co's Enterprise Value is 円16,159 Mil. WIN-Partners Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,441 Mil. Therefore, WIN-Partners Co's EV-to-EBIT for today is 6.62.

The historical rank and industry rank for WIN-Partners Co's EV-to-EBIT or its related term are showing as below:

TSE:3183' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.17   Med: 6.97   Max: 16.14
Current: 6.62

During the past 13 years, the highest EV-to-EBIT of WIN-Partners Co was 16.14. The lowest was 2.17. And the median was 6.97.

TSE:3183's EV-to-EBIT is ranked better than
74.07% of 81 companies
in the Medical Distribution industry
Industry Median: 12.94 vs TSE:3183: 6.62

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. WIN-Partners Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円17,333 Mil. WIN-Partners Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,441 Mil. WIN-Partners Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 14.08%.


WIN-Partners Co EV-to-EBIT Historical Data

The historical data trend for WIN-Partners Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co EV-to-EBIT Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.40 4.02 5.80 4.83 4.11

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.93 4.11 4.55 4.97 7.10

Competitive Comparison of WIN-Partners Co's EV-to-EBIT

For the Medical Distribution subindustry, WIN-Partners Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's EV-to-EBIT falls into.



WIN-Partners Co EV-to-EBIT Calculation

WIN-Partners Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=16158.980/2440.651
=6.62

WIN-Partners Co's current Enterprise Value is 円16,159 Mil.
WIN-Partners Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,441 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co  (TSE:3183) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

WIN-Partners Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=2440.651/17333.337
=14.08 %

WIN-Partners Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円17,333 Mil.
WIN-Partners Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,441 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines